The Aflac Foundation donating $1.5 million to the Aflac Cancer and Blood Disorders Center.

176

Kathelen Amos, President of The Aflac Foundation, emphasized the importance of supporting clinical research for the benefit of patients worldwide, starting with those at the Cancer Center. The donation aims to aid the center in providing comprehensive care to over 2,600 children and young adults with sickle cell disease annually. Specifically, the funds will support critical positions such as psychologists, social workers, and teachers at the Hughes Spalding clinic, essential roles that rely on philanthropic support to continue.

The Aflac Cancer and Blood Disorders Center is renowned for its active involvement in pediatric clinical trials, offering patients access to over 380 clinical studies. Over the past nine years, the center has significantly expanded its research capabilities, increasing the number of full-time research employees and investigator-initiated clinical trials. Research efforts focus on various aspects of sickle cell disease, including chronic pain management, anemia testing, opioid treatment, and stroke prevention.

Dr. Beatrice E. Gee, Director of the Aflac Sickle Cell Disease Program, and Dr. Jason Payne, Hughes Spalding Campus Director, expressed gratitude for the Aflac Foundation’s unwavering commitment, acknowledging its profound impact on the lives of patients and the community.